Evidence map›Paper›PMID 38023715›Full record

ArticleBioengineering & translational medicine2023

Personalized additive manufacturing of devices for the management of enteroatmospheric fistulas.

Francisco José Calero Castro, Andrés Padillo Eguía, Virginia Durán Muñoz-Cruzado, Luis Tallón Aguilar, José Tinoco González, Imán Laga, Fernando de la Portilla de Juan, Felipe Pareja Ciuró, Javier Padillo Ruiz

Abstract read
In one paragraph

Article in Bioengineering & translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francisco José Calero CastroOncology Surgery, Cell Therapy, and Organ Transplantation Group, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla Seville Spain.ORCID https://orcid.org/0000-0002-6039-3091
Andrés Padillo EguíaUniversity of Seville Seville Spain.
Virginia Durán Muñoz-CruzadoOncology Surgery, Cell Therapy, and Organ Transplantation Group, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla Seville Spain.ORCID https://orcid.org/0000-0003-4499-0483
Luis Tallón AguilarOncology Surgery, Cell Therapy, and Organ Transplantation Group, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla Seville Spain.
José Tinoco GonzálezOncology Surgery, Cell Therapy, and Organ Transplantation Group, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla Seville Spain.
Imán LagaOncology Surgery, Cell Therapy, and Organ Transplantation Group, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla Seville Spain.
Fernando de la Portilla de JuanOncology Surgery, Cell Therapy, and Organ Transplantation Group, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla Seville Spain.
Felipe Pareja CiuróOncology Surgery, Cell Therapy, and Organ Transplantation Group, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla Seville Spain.ORCID https://orcid.org/0000-0001-9192-3465
Javier Padillo RuizOncology Surgery, Cell Therapy, and Organ Transplantation Group, Instituto de Biomedicina de Sevilla (IBiS) Hospital Universitario Virgen del Rocío, CSIC, Universidad de Sevilla Seville Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Additive manufacturing techniques allow the customized design of medical devices according to the patient's requirements. Enteroatmospheric fistula is a pathology that benefits from this personalization due to its extensive clinical variability since the size and morphology of the wound differ extensively among patients. Standard prosthetics do not achieve proper isolation of the wound, leading to a higher risk of infections. Currently, no effective personalized technique to isolate it has been described. In this work, we present the workflow for the design and manufacture of customized devices adapted to the fistula characteristics as it evolves and changes during the treatment with Negative Pressure Wound Therapy (NPWT). For each case, a device was designed with dimensions and morphology depending on each patient's requirements using white light scanning, CAD design, and additive manufacturing. The design and manufacture of the devices were performed in 230.50 min (184.00-304.75). After the placement of the device, the wound was successfully isolated from the intestinal content for 48-72 h. The therapy was applied for 27.71 ± 13.74 days, and the device was redesigned to adapt to the wound when geometrical evolutionary changes occur during the therapy. It was observed a decrease in weekly cures from 23.63 ± 10.54 to 2.69 ± 0.65 (

Indexed as

3D printingcomputer‐aided designdigestive system fistulapersonalized medicinewound carewound healing

Identifiers

PMID38023715
PMCPMC10658531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.